Final Results Of A Phase 2 Study Of Vorinostat Plus Rituximab In Newly Diagnosed, Relapsed Or Refractory Indolent Non-Hodgkin's Lymphoma

Autor: Chen, Robert, Frankel, Paul *, Popplewell, Leslie *, Siddiqi, Tanya, Ye, Wei *, Conrad, Joel *, Mott, Michelle *, Nademanee, Auayporn *, Htut, Myo, Forman, Stephen J., Kirschbaum, Mark
Zdroj: In Blood 15 November 2013 122(21):4398-4398
Databáze: ScienceDirect